What to expect when you take Tekturna and Lotrel?

Do you take Tekturna and Lotrel? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 21, 2018

4,024 reports have been studied.


Females aged 50 to 59 :

2,064 related reports were analyzed:

Most common symptoms:

Anaemia
  • 5.71% for females aged 50 (±5) who take Lotrel
Chest pain
  • 7.4% for females aged 50 (±5) who take Lotrel
Depression
  • 6.56% for females aged 50 (±5) who take Lotrel
Diarrhea
  • 7.19% for females aged 50 (±5) who take Lotrel
Dizziness
  • 7.48% for females aged 50 (±5) who take Lotrel
Dyspnea
  • 8.53% for females aged 50 (±5) who take Lotrel
  • 5.11% for females aged 50 (±5) who take Tekturna
Fatigue
  • 7.62% for females aged 50 (±5) who take Lotrel
Headache
  • 7.12% for females aged 50 (±5) who take Lotrel
  • 6.19% for females aged 50 (±5) who take Tekturna
High blood pressure
  • 11.46% for females aged 50 (±5) who take Tekturna
  • 7.76% for females aged 50 (±5) who take Lotrel
Hypoaesthesia
  • 5.15% for females aged 50 (±5) who take Lotrel
Injury
  • 5.43% for females aged 50 (±5) who take Lotrel
Joint pain
  • 5.85% for females aged 50 (±5) who take Lotrel
Nausea
  • 11.0% for females aged 50 (±5) who take Lotrel
  • 6.04% for females aged 50 (±5) who take Tekturna
Nausea and vomiting
  • 5.29% for females aged 50 (±5) who take Lotrel
Oedema peripheral
  • 6.98% for females aged 50 (±5) who take Lotrel
Pain
  • 9.31% for females aged 50 (±5) who take Lotrel
Pain in extremity
  • 6.56% for females aged 50 (±5) who take Lotrel
Paraesthesia
  • 5.71% for females aged 50 (±5) who take Lotrel
Rashes
  • 7.74% for females aged 50 (±5) who take Tekturna
Renal impairment
  • 5.42% for females aged 50 (±5) who take Tekturna
Stress and anxiety
  • 8.32% for females aged 50 (±5) who take Lotrel
Urinary tract infection
  • 6.7% for females aged 50 (±5) who take Lotrel
Weakness
  • 8.67% for females aged 50 (±5) who take Lotrel
Weight decreased
  • 5.64% for females aged 50 (±5) who take Lotrel

Most common co-existing conditions:

Atrial fibrillation/flutter
  • 5.57% for females aged 50 (±5) who take Tekturna
Cardiac failure
  • 7.89% for females aged 50 (±5) who take Tekturna
Depression
  • 5.15% for females aged 50 (±5) who take Lotrel
Diabetes
  • 6.81% for females aged 50 (±5) who take Tekturna
  • 5.85% for females aged 50 (±5) who take Lotrel
High blood cholesterol
  • 7.48% for females aged 50 (±5) who take Lotrel
Multiple sclerosis
  • 5.57% for females aged 50 (±5) who take Lotrel
Rheumatoid arthritis
  • 6.77% for females aged 50 (±5) who take Lotrel
back to top

Males aged 50 to 59 :

1,960 related reports were analyzed:

Most common symptoms:

Blood creatinine increased
  • 7.45% for males aged 50 (±5) who take Tekturna
Cardiac failure
  • 5.86% for males aged 50 (±5) who take Tekturna
Chest pain
  • 5.7% for males aged 50 (±5) who take Lotrel
Concomitant disease progression
  • 5.49% for males aged 50 (±5) who take Tekturna
Diarrhea
  • 5.17% for males aged 50 (±5) who take Lotrel
Dyspnea
  • 6.59% for males aged 50 (±5) who take Tekturna
Fatigue
  • 5.61% for males aged 50 (±5) who take Lotrel
Heart attack
  • 8.76% for males aged 50 (±5) who take Lotrel
High blood pressure
  • 8.3% for males aged 50 (±5) who take Tekturna
  • 6.57% for males aged 50 (±5) who take Lotrel
Nausea
  • 6.31% for males aged 50 (±5) who take Lotrel
Oedema peripheral
  • 5.37% for males aged 50 (±5) who take Tekturna
Stroke
  • 6.05% for males aged 50 (±5) who take Lotrel

Most common co-existing conditions:

Cardiac failure
  • 15.02% for males aged 50 (±5) who take Tekturna
Depression
  • 5.35% for males aged 50 (±5) who take Lotrel
Diabetes
  • 10.25% for males aged 50 (±5) who take Lotrel
  • 9.28% for males aged 50 (±5) who take Tekturna
High blood cholesterol
  • 11.39% for males aged 50 (±5) who take Lotrel
Hyperlipidaemia
  • 6.84% for males aged 50 (±5) who take Tekturna
Pain
  • 5.08% for males aged 50 (±5) who take Lotrel
Type 2 diabetes
  • 5.49% for males aged 50 (±5) who take Tekturna
  • 5.43% for males aged 50 (±5) who take Lotrel
back to top

Do you take Tekturna and Lotrel:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Tekturna

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. (latest outcomes from Tekturna 4,384 users)

Lotrel

Lotrel has active ingredients of amlodipine besylate; benazepril hydrochloride. It is often used in high blood pressure. (latest outcomes from Lotrel 12,223 users)

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.